Automated Meibomian Gland Expression Device for Painless Diagnosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Diagnosing meibomian gland dysfunction is challenging due to the lack of visible indicators, making it difficult to determine if meibomian glands are obstructed, and current methods can be painful and variable, leading to inaccurate diagnoses.
Innovation Solution
A standardized method using an evaluation tool to apply a controlled force to simulate blinking, allowing for the assessment of meibomian gland secretion grades and scores to determine obstruction, which is painless, objective, and repeatable.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If manual expression methods are used to diagnose meibomian gland dysfunction, then secretion can be obtained for evaluation, but the procedure becomes painful and variable leading to inaccurate diagnoses
Solution Approach 1:
The patent replaces manual mechanical expression with an automated expression device that applies controlled, standardized forces to the eyelid. This mechanical substitution eliminates the variability and pain associated with manual finger pressure while maintaining the ability to express meibomian gland secretions for diagnostic evaluation.
Solution Approach 2:
The invention changes the parameters of the expression method by implementing standardized force magnitude, duration, and application points. This parameter standardization transforms the subjective, variable manual process into an objective, repeatable automated procedure that reduces patient pain while improving measurement precision.
2Reliability
If manual expression methods are used, then diagnosis can be performed, but variability in application leads to inaccurate and non-repeatable results
Solution Approach 1:
The automated expression device replaces manual mechanical expression with a programmable system that delivers consistent, standardized forces. This substitution eliminates operator variability in force application, duration, and positioning, thereby improving both the reliability and precision of diagnostic results.
Solution Approach 2:
The system incorporates feedback mechanisms that monitor and record the expression parameters (force, duration, secretion volume and quality). This feedback enables verification of standardized application and provides objective data for consistent, repeatable diagnoses across different patients and time points.
3Measurement precision
If standardized automated expression is implemented, then measurement precision and reliability improve, but device complexity increases
Solution Approach 1:
While the automated device does increase mechanical complexity compared to manual expression, this substitution is necessary to achieve the standardized, precise measurements required for accurate MGD diagnosis. The complexity is justified by the significant improvement in measurement precision and elimination of operator variability.
Solution Approach 2:
The automated expression device is designed to perform multiple functions: applying standardized force, collecting secretion samples, and providing objective measurement data. This multi-functionality consolidates what would otherwise require multiple separate manual operations into a single integrated system, making the complexity manageable while delivering comprehensive diagnostic capability.
Data Source
AI summary
Methods of diagnosing meibomian gland dysfunction are disclosed. The methods may be standardized and provide an accurate diagnosis of whether meibomian gland dysfunction exists. In one embodiment, a method is provided that utilizes an evaluation tool to apply a force for a preselected period of time to at least one of a plurality of meibomian glands in two or more regions of a plurality of regions of an eyelid. A grade is assigned to the at least one meibomian gland of the plurality of meibomian glands in each of the two or more regions based on any secretion that is expressed from each meibomian gland. In this manner, a plurality of meibomian gland secretion grades is obtained. The plurality of meibomian gland secretion grades is indicative of the presence of meibomian gland dysfunction.